37 results on '"Ng, Cheng Han"'
Search Results
2. Meta‐analysis: Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis
3. Sex-based Disparities in Liver Transplantation for Hepatocellular Carcinoma and the Impact of the Growing Burden of NASH
4. Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis
5. Metabolic Syndrome and Metabolic Dysfunction-Associated Steatotic Liver Disease in Premenopausal Women: Global Trends and Projections to 2040
6. Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019
7. The Global Burden of Alcohol-associated Cirrhosis and Cancer in Young and Middle-aged Adults
8. Impact of Pretransplant Diabetes on Outcomes After Liver Transplantation: An Updated Meta-analysis With Systematic Review
9. Global and regional burden of alcohol-associated liver disease and alcohol use disorder in the elderly
10. Rising global burden of cancer attributable to high BMI from 2010 to 2019
11. Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies
12. Donor Diabetes and Steatosis Affects Recipient Survival Following Liver Transplantation Based on Etiology of Liver Cirrhosis
13. Global Prevalence, Clinical Characteristics, Surveillance, Treatment Allocation, and Outcomes of Alcohol-Associated Hepatocellular Carcinoma
14. Sequential SAFE Score and Transient Elastography for Detecting Significant Fibrosis in Asian Patients with MASLD
15. NASH is the Leading Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
16. WED-282 Prevalence of LowFibrosis-4 Score in Patients with MASLD-related Hepatocellular Carcinoma: Results from a Multicentre Cohort Study
17. SAT-281 Clinical characteristics, surveillance, treatment allocation and outcomes of alcohol-related hepatocellular carcinoma: meta-analysis of 37 studies and 66, 559 patients
18. SAT-256 Liver-related complications are the fastest growing cause of mortality from alcohol consumption: results from the global burden of disease 2019 study
19. FRI-236-YI Racial disparities in incidence of cirrhosis and extrahepatic manifestations in metabolic dysfunction-associated steatotic liver disease
20. TOP-004 Impact of MELD 3.0 on waitlist outcomes of metabolic dysfunction-associated steatohepatitis cirrhosis among liver transplant waitlist registrants
21. Socio‐economic association of alcohol use disorder and cardiovascular and alcohol‐associated liver disease from 2010 to 2019
22. Incidence of liver cancer in young adults according to the global burden of disease database 2019
23. Changing global epidemiology of chronic hepatitis C virus-related outcomes from 2010 to 2019: cirrhosis is the growing burden of hepatitis C virus-related disease
24. Upper limit of normal ALT levels in health and metabolic diseases: Pooled analysis of 423,355 individuals with bootstrap modelling
25. Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis: Systematic review and meta‐analysis
26. The Global Burden of Alcohol-associated Cirrhosis and Cancer in Young and Middle-aged Adults
27. Disparities among ethnic groups in mortality and outcomes among adults with MASLD: A multicenter study.
28. Gut‐liver axis: Potential mechanisms of action of food‐derived extracellular vesicles.
29. Usefulness of health checkup‐based indices in identifying metabolic dysfunction‐associated steatotic liver disease.
30. Su1590 PREVALENCE OF CIRRHOSIS AND EXTRAHEPATIC MANIFESTATIONS AMONG LEAN AND NON-LEAN INDIVIDUALS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
31. Su1534 RACIAL DISPARITIES IN PREVALENCE OF CIRRHOSIS AND EXTRAHEPATIC MANIFESTATIONS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
32. NASH is the Leading Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.
33. Comparative efficacy of THR-β agonists, FGF-21 analogues, GLP-1R agonists, GLP-1-based polyagonists, and Pan-PPAR agonists for MASLD: A systematic review and network meta-analysis.
34. Comparative efficacy of pharmacologic therapies for MASH in reducing liver fat content: Systematic review and network meta-analysis.
35. The Burden of Overweight and Obesity-Associated Gastrointestinal Cancers in Low and Lower-Middle-Income Countries: A Global Burden of Disease 2019 Analysis.
36. From Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated Liver Disease and Alcohol Use Disorder in Young Women.
37. The incidence of adverse outcome in donors after living donor liver transplantation: A meta-analysis of 60,829 donors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.